Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06-17

AUTHORS

S. Zhao, D. Cheng, E. Liu, H. Yu, H. Yang, X. Xue, Y. Chu

ABSTRACT

It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, α-2a and α-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar. More... »

PAGES

1183-1192

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8

DOI

http://dx.doi.org/10.1007/s10096-008-0557-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014821552

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18560911


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepacivirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon alpha-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyethylene Glycols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ribavirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "S.", 
        "id": "sg:person.01217761561.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics of the First Affiliated Hospital, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pediatrics of the First Affiliated Hospital, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "D.", 
        "id": "sg:person.0656247150.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "E.", 
        "id": "sg:person.016446245112.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.452438.c", 
          "name": [
            "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Public Health, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Public Health, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "H.", 
        "id": "sg:person.01353407225.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353407225.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xue", 
        "givenName": "X.", 
        "id": "sg:person.0772655513.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772655513.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Immunology and Microbiology, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chu", 
        "givenName": "Y.", 
        "id": "sg:person.01132665065.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2008-06-17", 
    "datePublishedReg": "2008-06-17", 
    "description": "It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, \u03b1-2a and \u03b1-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10096-008-0557-8", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4942147", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "human immunodeficiency virus", 
      "hepatitis C virus", 
      "higher SVR", 
      "HCV/HIV-coinfected patients", 
      "higher sustained response rates", 
      "sustained response rate", 
      "chronic hepatitis patients", 
      "treatment of patients", 
      "serious adverse effects", 
      "types of peginterferon", 
      "MEDLINE literature search", 
      "HIV patients", 
      "hepatitis patients", 
      "HCV genotypes", 
      "immunodeficiency virus", 
      "C virus", 
      "genotype 1", 
      "\u03b1-2a", 
      "peginterferon", 
      "\u03b1-2b", 
      "patients", 
      "response rate", 
      "genotype infections", 
      "interferon", 
      "literature search", 
      "adverse effects", 
      "ribavirin", 
      "virus", 
      "treatment", 
      "withdrawal rate", 
      "selection criteria", 
      "SVR", 
      "different genotypes", 
      "RCTs", 
      "therapy", 
      "infection", 
      "trials", 
      "genotypes", 
      "study", 
      "rate", 
      "aim", 
      "respective types", 
      "criteria", 
      "likelihood", 
      "types", 
      "effect", 
      "search", 
      "comparison", 
      "probability"
    ], 
    "name": "Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients", 
    "pagination": "1183-1192", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014821552"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-008-0557-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18560911"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-008-0557-8", 
      "https://app.dimensions.ai/details/publication/pub.1014821552"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_469.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10096-008-0557-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-008-0557-8'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      20 PREDICATES      94 URIs      85 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-008-0557-8 schema:about N0d89f9bfa01742379e31e14e486228f2
2 N1188cf6d21584cffb7f18357e800e38b
3 N17388ba79f2d4a138cf3a8d1ecddfcdf
4 N36965b119c944ef0a084da7f2aa36a9c
5 N4a4b85de08b64aaa80dc1ca7f04609bd
6 N572a84f98e6e4f8f9b47a9ae744d582f
7 N573e5822d77b47c6857c298192e1e7a7
8 N825279a6c620436888fdb8e8dc6e0fff
9 N8d3000a9aa2242bc9583485a2f07aaf1
10 N8e612e97b8b7430ea46b0e6d998ac089
11 N9387731bca084f689c620be14ab1b74b
12 N95a80c76b36a43feb56e93a40b042ae6
13 Nb159751fbd914a63af29bd61d7e4df1a
14 Nb403394203ea4100b3caedae10449b0e
15 Nb7e275a280f847dcb04a4ee4b1a13956
16 Nc897b411f1d549d4a997313873beddde
17 Nd20e6416b99f41aba947980ae2f5ea1a
18 Ned73bdc3a6d24aaaa6721d434c702892
19 Nef4bfc06a05b442eb4f46b70fc2505ae
20 anzsrc-for:11
21 anzsrc-for:1103
22 anzsrc-for:1108
23 schema:author N96025783e0874ff497db95428b3b1692
24 schema:datePublished 2008-06-17
25 schema:datePublishedReg 2008-06-17
26 schema:description It remains difficult to achieve high sustained response rates (SVRs) in chronic hepatitis patients coinfected with human immunodeficiency virus (HIV). The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon with interferon in the treatment of patients carrying different genotypes of hepatitis C virus (HCV) and coinfected with HIV. A Medline literature search was conducted to identify RCTs evaluating SVRs to peginterferon and interferon in HCV/HIV-coinfected patients. Six studies matched the selection criteria, and the HCV genotype of 1,717 coinfected patients was reported. For genotypes 1 or 4 HCV and HIV-coinfected patients, both types of peginterferon, α-2a and α-2b, achieved higher SVRs compared with the respective types of interferon. The SVRs achieved in patients infected with HCV genotypes 1 or 4 treated with peginterferon and ribavirin was not satisfactory in comparison with those of patients infected with HCV genotypes 2 or 3 (26% vs. 55%). The probability of achieving higher SVRs in patients when treated with peginterferon plus ribavirin increased compared with other therapies, especially for patients coinfected with HCV genotypes 1 or 4 and HIV. The likelihoods of serious adverse effects and withdrawal rates were similar.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf N397a6651651c4752b944ee535a314675
30 N6520ba99dc3b4704b631ca1d066f757a
31 sg:journal.1093599
32 schema:keywords C virus
33 HCV genotypes
34 HCV/HIV-coinfected patients
35 HIV patients
36 MEDLINE literature search
37 RCTs
38 SVR
39 adverse effects
40 aim
41 chronic hepatitis patients
42 comparison
43 criteria
44 different genotypes
45 effect
46 genotype 1
47 genotype infections
48 genotypes
49 hepatitis C virus
50 hepatitis patients
51 higher SVR
52 higher sustained response rates
53 human immunodeficiency virus
54 immunodeficiency virus
55 infection
56 interferon
57 likelihood
58 literature search
59 patients
60 peginterferon
61 probability
62 rate
63 respective types
64 response rate
65 ribavirin
66 search
67 selection criteria
68 serious adverse effects
69 study
70 sustained response rate
71 therapy
72 treatment
73 treatment of patients
74 trials
75 types
76 types of peginterferon
77 virus
78 withdrawal rate
79 α-2a
80 α-2b
81 schema:name Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients
82 schema:pagination 1183-1192
83 schema:productId N1c37647afdfe4275bd13558a71f3cbb5
84 N547ac5ee742d4b4fae12e13a0e1bb30a
85 N5cee118c47034047ab1f4c9d4715e3e4
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014821552
87 https://doi.org/10.1007/s10096-008-0557-8
88 schema:sdDatePublished 2022-12-01T06:26
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N4a5913de570047a0b9ea9a280cbefc6e
91 schema:url https://doi.org/10.1007/s10096-008-0557-8
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N0d89f9bfa01742379e31e14e486228f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adult
97 rdf:type schema:DefinedTerm
98 N1188cf6d21584cffb7f18357e800e38b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Male
100 rdf:type schema:DefinedTerm
101 N17388ba79f2d4a138cf3a8d1ecddfcdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Interferon-alpha
103 rdf:type schema:DefinedTerm
104 N1c37647afdfe4275bd13558a71f3cbb5 schema:name doi
105 schema:value 10.1007/s10096-008-0557-8
106 rdf:type schema:PropertyValue
107 N27ce3de49027452887f51825d4cd24eb rdf:first Naecf1ba85eb345d8bae9644c9d781514
108 rdf:rest N32ce5459d9c84630947e9737bf621539
109 N28385b0a5afb4799b67d65d07c1e3c10 rdf:first sg:person.0772655513.43
110 rdf:rest Ne1703a70dbb34f2f9bf097b950e0fef1
111 N32ce5459d9c84630947e9737bf621539 rdf:first sg:person.01353407225.43
112 rdf:rest N28385b0a5afb4799b67d65d07c1e3c10
113 N36965b119c944ef0a084da7f2aa36a9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Middle Aged
115 rdf:type schema:DefinedTerm
116 N397a6651651c4752b944ee535a314675 schema:issueNumber 12
117 rdf:type schema:PublicationIssue
118 N4a4b85de08b64aaa80dc1ca7f04609bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Treatment Outcome
120 rdf:type schema:DefinedTerm
121 N4a5913de570047a0b9ea9a280cbefc6e schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N547ac5ee742d4b4fae12e13a0e1bb30a schema:name dimensions_id
124 schema:value pub.1014821552
125 rdf:type schema:PropertyValue
126 N572a84f98e6e4f8f9b47a9ae744d582f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Randomized Controlled Trials as Topic
128 rdf:type schema:DefinedTerm
129 N573e5822d77b47c6857c298192e1e7a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Ribavirin
131 rdf:type schema:DefinedTerm
132 N5cee118c47034047ab1f4c9d4715e3e4 schema:name pubmed_id
133 schema:value 18560911
134 rdf:type schema:PropertyValue
135 N6520ba99dc3b4704b631ca1d066f757a schema:volumeNumber 27
136 rdf:type schema:PublicationVolume
137 N825279a6c620436888fdb8e8dc6e0fff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Recombinant Proteins
139 rdf:type schema:DefinedTerm
140 N8d3000a9aa2242bc9583485a2f07aaf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Drug Therapy, Combination
142 rdf:type schema:DefinedTerm
143 N8e612e97b8b7430ea46b0e6d998ac089 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Interferon alpha-2
145 rdf:type schema:DefinedTerm
146 N9387731bca084f689c620be14ab1b74b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Humans
148 rdf:type schema:DefinedTerm
149 N95a80c76b36a43feb56e93a40b042ae6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Hepacivirus
151 rdf:type schema:DefinedTerm
152 N96025783e0874ff497db95428b3b1692 rdf:first sg:person.01217761561.81
153 rdf:rest Nb6f702b16c2b4468be87d499401f451e
154 Naecf1ba85eb345d8bae9644c9d781514 schema:affiliation grid-institutes:grid.452438.c
155 schema:familyName Yu
156 schema:givenName H.
157 rdf:type schema:Person
158 Nb159751fbd914a63af29bd61d7e4df1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Female
160 rdf:type schema:DefinedTerm
161 Nb403394203ea4100b3caedae10449b0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Interferons
163 rdf:type schema:DefinedTerm
164 Nb6f702b16c2b4468be87d499401f451e rdf:first sg:person.0656247150.94
165 rdf:rest Nd0b36c3b8caa4fef881815bee73ca0c8
166 Nb7e275a280f847dcb04a4ee4b1a13956 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Genotype
168 rdf:type schema:DefinedTerm
169 Nc897b411f1d549d4a997313873beddde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name HIV Infections
171 rdf:type schema:DefinedTerm
172 Nd0b36c3b8caa4fef881815bee73ca0c8 rdf:first sg:person.016446245112.43
173 rdf:rest N27ce3de49027452887f51825d4cd24eb
174 Nd20e6416b99f41aba947980ae2f5ea1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Polyethylene Glycols
176 rdf:type schema:DefinedTerm
177 Ne1703a70dbb34f2f9bf097b950e0fef1 rdf:first sg:person.01132665065.66
178 rdf:rest rdf:nil
179 Ned73bdc3a6d24aaaa6721d434c702892 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Antiviral Agents
181 rdf:type schema:DefinedTerm
182 Nef4bfc06a05b442eb4f46b70fc2505ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Hepatitis C, Chronic
184 rdf:type schema:DefinedTerm
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
189 schema:name Clinical Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical Microbiology
193 rdf:type schema:DefinedTerm
194 sg:grant.4942147 http://pending.schema.org/fundedItem sg:pub.10.1007/s10096-008-0557-8
195 rdf:type schema:MonetaryGrant
196 sg:journal.1093599 schema:issn 0934-9723
197 1435-4373
198 schema:name European Journal of Clinical Microbiology & Infectious Diseases
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01132665065.66 schema:affiliation grid-institutes:grid.43169.39
202 schema:familyName Chu
203 schema:givenName Y.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132665065.66
205 rdf:type schema:Person
206 sg:person.01217761561.81 schema:affiliation grid-institutes:grid.43169.39
207 schema:familyName Zhao
208 schema:givenName S.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81
210 rdf:type schema:Person
211 sg:person.01353407225.43 schema:affiliation grid-institutes:grid.43169.39
212 schema:familyName Yang
213 schema:givenName H.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353407225.43
215 rdf:type schema:Person
216 sg:person.016446245112.43 schema:affiliation grid-institutes:grid.43169.39
217 schema:familyName Liu
218 schema:givenName E.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43
220 rdf:type schema:Person
221 sg:person.0656247150.94 schema:affiliation grid-institutes:grid.43169.39
222 schema:familyName Cheng
223 schema:givenName D.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656247150.94
225 rdf:type schema:Person
226 sg:person.0772655513.43 schema:affiliation grid-institutes:grid.43169.39
227 schema:familyName Xue
228 schema:givenName X.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772655513.43
230 rdf:type schema:Person
231 grid-institutes:grid.43169.39 schema:alternateName Department of Immunology and Microbiology, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
232 Department of Pediatrics of the First Affiliated Hospital, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
233 Department of Public Health, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
234 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
235 schema:name Department of Immunology and Microbiology, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
236 Department of Pediatrics of the First Affiliated Hospital, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
237 Department of Public Health, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
238 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
239 rdf:type schema:Organization
240 grid-institutes:grid.452438.c schema:alternateName Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 710061, Shaanxi, China
241 schema:name Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 710061, Shaanxi, China
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...